Target intelligence / Profile preview

Glutaredoxin 5 (GLRX5)

Target
GLRX5
Molecular classification
Enzyme, Oxidoreductase, Iron–sulfur cluster protein
01

Overview

Glutaredoxin 5 (GLRX5) is a mitochondrial monothiol glutaredoxin enzyme responsible for the assembly and transfer of iron–sulfur (Fe/S) clusters, which are vital prosthetic groups in many cellular proteins, especially those involved in mitochondrial respiration and DNA synthesis[1][3]. It uses glutathione as a cofactor to maintain redox balance and facilitate Fe/S delivery to target apoproteins[1][2][3]. GLRX5 plays a key role in erythropoiesis and the biosynthesis of hemoglobin, and its deficiency disrupts mitochondrial iron homeostasis, leading to iron accumulation, oxidative stress, and impaired activity of Fe/S-dependent enzymes[1][3]. Although GLRX5 is not currently a direct drug target, its dysfunction has been linked to inherited forms of sideroblastic anemia and possibly mitochondrial and neurodegenerative diseases[1][3].

Other names
GLRX5GRX5glutaredoxin-5mitochondrial glutaredoxin 5
02

Biological functions

Iron–sulfur cluster assembly and transferMaintenance of mitochondrial iron homeostasisRedox regulation (maintaining thiol/disulfide balance)Electron donor to ribonucleotide reductaseErythropoiesis (influencing hemoglobin synthesis)
03

Disease associations

Anemia (e.g., sideroblastic anemia due to dysfunctional Fe/S cluster assembly)Mitochondrial diseasesPossible roles in neurodegeneration (through oxidative stress)Iron metabolism disorders
04

Safety considerations

None described for direct targeting; theoretical concerns would involve disturbance of redox homeostasis and mitochondrial iron metabolism

Beyond the preview

Go deeper on Glutaredoxin 5 (GLRX5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutaredoxin 5 (GLRX5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call